Mannitol Versus Supportive Care in Ciguatera Fish Poisoning

Sponsor
University of South Florida (Other)
Overall Status
Unknown status
CT.gov ID
NCT02570971
Collaborator
Florida Poison Control Center (Other)
200
2

Study Details

Study Description

Brief Summary

Ciguatera poisoning, caused by the ingestion of ciguatoxin-containing fish, is a global public health concern. In the US, the vast majority of ciguatera poisonings occur in Florida, followed by Hawaii and California. Equipoise exists in the medical literature regarding the effectiveness of mannitol therapy in treatment of ciguatera poisoning. While there are many case reports attesting to its utility, the only randomized control trial (RCT) comparing mannitol therapy with supportive care failed to show any significant benefit from mannitol treatment for a variety of clinical outcomes. Investigators therefore propose a second, larger RCT to test this question.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Mannitol Versus Supportive Care in Ciguatera Fish Poisoning: A Randomized Control Trial
Study Start Date :
Oct 1, 2015
Anticipated Primary Completion Date :
Jun 1, 2018

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Patients will receive supportive care measures.

Experimental: Investigational

Patients will receive 500mL of 20% mannitol

Drug: Mannitol

Outcome Measures

Primary Outcome Measures

  1. Symptom score [24 hours]

    Covers a variety of neurological and gastrointestinal symptoms on a 0-4 score

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • History consistent with ciguatera poisoning
Exclusion Criteria:
  • Minors

  • pregnant patients

  • those unable to give consent

  • severe congestive heart failure or renal failure

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of South Florida
  • Florida Poison Control Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of South Florida
ClinicalTrials.gov Identifier:
NCT02570971
Other Study ID Numbers:
  • CITX-2015
First Posted:
Oct 7, 2015
Last Update Posted:
Oct 7, 2015
Last Verified:
Oct 1, 2015
Keywords provided by University of South Florida
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 7, 2015